The first Gain Therapeutics trade was made in Q2 2022.
Since then Jim Simons bought shares five more times and sold shares on five occasions. The investor completely sold their stake between Q3 2024 and Q4 2024.
Avg closing price
Price range
Sold -53.3 Thousand shares
Q4 2024
Avg closing price
$2.00
Price range
$1.56
-
$2.92
Sold 55.1% shares (-65.4 Thousand shares)
Q3 2024
Avg closing price
$1.25
Price range
$0.94
-
$1.99
Increased shares by 154.2% (+72 Thousand shares)
Q2 2024
Avg closing price
$2.60
Price range
$1.24
-
$3.99
Increased shares by 9.1% (+3.9 Thousand shares)
Q1 2024
Avg closing price
$4.15
Price range
$3.22
-
$5.04
Sold 8.7% shares (-4.1 Thousand shares)
Q4 2023
Avg closing price
$2.78
Price range
$2.07
-
$3.40
Sold 1.5% shares (-700 shares)
Q3 2023
Avg closing price
$3.79
Price range
$3.19
-
$4.68
Increased shares by 23.0% (+8.9 Thousand shares)
Q2 2023
Avg closing price
$4.88
Price range
$4.36
-
$5.50
Increased shares by 16.6% (+5.5 Thousand shares)
Q1 2023